ESHRE Guideline: management of women with premature ovarian insufficiency. - Wikidata - awgldk - TriplyDB

ESHRE Guideline: management of women with premature ovarian insufficiency.

ESHRE Guideline: management of women with premature ovarian insufficiency.

http://www.wikidata.org/entity/Q38786469

about

Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte.Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data.Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour.Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic.Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis.Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.Knowledge and attitudes of health professionals regarding menopausal hormone therapies.A mother's gift of life: exploring the concerns and ethical aspects of fertility preservation for mother-to-daughter oocyte donation.The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Occult form of premature ovarian insufficiency.Occult Form of Premature Ovarian Insufficiency in Women with Infertility and Oligomenorrhea as Assessed by Poor Ovarian Response Criteria.A common African variant of human connexin 37 is associated with Caucasian primary ovarian insufficiency and has a deleterious effect in vitro.The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.Premature Ovarian Insufficiency - an update on recent advances in understanding and management.Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review.Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.MicroRNA-379-5p is associate with biochemical premature ovarian insufficiency through PARP1 and XRCC6.Standard hormone therapy is inadequate for bone density in premature ovarian insufficiency.POLR2C Mutations Are Associated With Primary Ovarian Insufficiency in Women.Consanguineous familial study revealed biallelic FIGLA mutation associated with premature ovarian insufficiency.Use of Hormone Replacement in Females with Endocrine Disorders Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences Signs and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiency Premature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluation Bone health and evaluation of bone mineral density in patients with premature ovarian insufficiency Reproduction in premature ovarian insufficiency patients - from latest studies to therapeutic approach Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

P2860

Q29147461-C6EDD91A-1EFB-45F4-8DDC-DECBE952FB88 Q36151280-8A321605-515B-4936-87E8-A4D4B7E2D28A Q36340348-7478B441-4520-49E5-AFA4-743C5227FB1E Q37519135-E5EE0745-F208-4406-9000-EB639D13717B Q38655598-2D8F2590-B82A-41C4-B96B-0B5EB7003CF9 Q38682205-ABDBA2BF-59EF-4D65-B26F-2B490723BDB9 Q38845245-30DB8666-F49B-40F4-B7A2-D286ED91C369 Q38853529-0779136D-CA86-451D-A2AE-EF415FCACEFB Q39000007-09D6CD43-664C-400C-BF81-BB2B929A2113 Q39001136-6C301936-EFE7-4F56-A7D2-FC470616C619 Q39271781-AEA2284E-9B30-4036-A79F-139B4B14EE1B Q46716306-74CE4C12-81CE-4019-9564-694D88C4B221 Q46985224-B3BFE5F8-CE73-4180-9572-83748B7C9190 Q47097531-31F4A437-F46C-48E9-BCB7-29620E0E1EB8 Q47101603-BEC426B2-FB39-458C-B0A3-00D22AAA9E87 Q47127165-CA1ABA34-D509-4B53-A4BE-B07439C6B80A Q47234054-54021856-4C82-4B03-9827-0FA13E063671 Q47262915-011C5A95-72DD-422F-9738-8F71F5A7760B Q47369122-FFFFD165-8BAC-4267-BB28-D92671C159A9 Q47779333-76C6D425-A405-40B3-A09A-4B3D37B7A66E Q48111424-F0014BC0-6A30-456D-95FC-E24EBB5AC19F Q48149291-2F66B19D-46F4-46EA-908A-46890ECB7888 Q49787194-B36F5671-BEDA-4E43-872B-C77F8067006A Q51031762-C5E7FAB2-A4F3-43F5-8508-DBBB8E7C2A76 Q52734978-1A4FC4DC-252B-4EE7-8BE6-E52A59D192FB Q55341378-A3D5EEF9-6937-4D3F-9D88-0A5CD13C7090 Q56029673-70AA553C-736E-41FD-A3AF-023BF7FD5183 Q57823050-5152FC76-F2A4-4AA6-80F7-B1FBE769D75F Q57823053-5A38BE4A-5063-41E3-8433-0BD9F497D7DC Q57823064-EE31A822-702B-4A54-9F77-1F5B77545C36 Q57823069-7C105717-43F1-44F7-A659-9596B74EFDB2 Q57823071-79D74B37-A5FE-49E8-BAD1-D558227E9B9C Q58768664-8771626D-AC70-4499-B12B-E9A9F696632F Q58793373-ABBE1E4A-E569-415D-8B0A-45E04AB710E1

P2860

ESHRE Guideline: management of women with premature ovarian insufficiency.

http://www.wikidata.org/entity/Q38786469

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

ESHRE Guideline: management of women with premature ovarian insufficiency.

@en

type

label

ESHRE Guideline: management of women with premature ovarian insufficiency.

@en

prefLabel

ESHRE Guideline: management of women with premature ovarian insufficiency.

@en

P1433

Q38786469-7B3BFC94-766B-453D-A80D-1B50F1D9CAB9

P1476

Q38786469-DD0F8E96-3E74-48EC-A66C-8A2BE00A110E

P2093

Q38786469-14E6899C-D7E6-459E-9DD8-04F15FA00FD1

Q38786469-23922F63-76D0-497F-9457-1D69A4CF9793

Q38786469-3C5C3485-F0BE-4524-8970-A1798BB5B0B4

Q38786469-4E309DFF-0E37-4723-8705-CFAB35C38603

Q38786469-628D45A3-D84F-4B28-A775-100DEEF98E10

Q38786469-636239FF-0101-44FC-B918-8BAF1A3555A6

Q38786469-B2C7A2CE-393D-478C-9CDE-3C0A1F5B533F

Q38786469-B5A2A492-D2AF-4735-A941-EE60B938B4C6

Q38786469-B60A2B02-6A96-4E88-8E73-60378F63AA75

Q38786469-C5579A5A-6FC7-48AB-B2A0-A92242AA86FA

P2860

Q38786469-02F24168-A556-494D-A4B5-AF0494B98189

Q38786469-0415D446-3115-4179-BB4A-86865679C796

Q38786469-046577F7-AFFE-408D-A65A-15165C1E4169

Q38786469-05810E20-F0D5-420C-BC08-1732008FFC93

Q38786469-08F47838-D494-476C-9017-D1A9CC3B466F

Q38786469-0981DCC5-9DEA-4D81-BED7-2565EC5CA347

Q38786469-0ECCD81D-C5F4-42CD-A251-6443F5C4FA1D

Q38786469-0ED17B5D-0121-4A0C-A2CE-30604F6841AA

Q38786469-10E0D59F-3D23-488B-8D02-86A228B8CC0D

Q38786469-12D16123-E27F-4FAD-852F-A7C6F5B59015

P304

Q38786469-30F9C166-CA29-4F31-87F7-003544B9E359

P31

Q38786469-11F0D7A7-E70F-4F3D-BB2A-502DE18922AE

P356

Q38786469-DFD71AC5-8736-4641-AD16-0390959385D7

P407

Q38786469-8098211D-BE27-4F9A-9923-4DE5352C8AFC

P433

Q38786469-EFFC7311-0F18-416D-8CA1-8BBBA56DAC9B

P478

Q38786469-792CD0E8-11F9-4EEE-82CC-EB0BACD0941A

P50

Q38786469-0D6720C0-692A-4D7B-8058-18C6C5B1A0BF

Q38786469-A2C4C62A-9C93-4913-A974-C9A1CE4C6A31

P577

Q38786469-5281D836-B4A3-4D66-8C52-A70084572497

P5875

Q38786469-65F44B39-1766-4A9D-8AC8-F5726EDC1922

P698

Q38786469-9740ED6E-8B3F-41E5-9F00-BD369606E428

P356

P1433

Human Reproduction

P1476

ESHRE Guideline: management of women with premature ovarian insufficiency.

@en

P2093

B Cartwright

http://www.w3.org/2001/XMLSchema#string

C Zillikens

http://www.w3.org/2001/XMLSchema#string

D Braat

http://www.w3.org/2001/XMLSchema#string

European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI

http://www.w3.org/2001/XMLSchema#string

F Janse

http://www.w3.org/2001/XMLSchema#string

J Bartlett

http://www.w3.org/2001/XMLSchema#string

L Liao

http://www.w3.org/2001/XMLSchema#string

L Webber

http://www.w3.org/2001/XMLSchema#string

M Davies

http://www.w3.org/2001/XMLSchema#string

N Vermeulen

http://www.w3.org/2001/XMLSchema#string

P2860

Non-hormonal interventions for hot flushes in women with a history of breast cancer

Local oestrogen for vaginal atrophy in postmenopausal women

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy

Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child

Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome

Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.

Fragile X testing in obstetrics and gynaecology in Canada.

Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles

P304

926-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEW027

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Renata Cífková

P577

2016-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299415735

http://www.w3.org/2001/XMLSchema#string

P698

27008889

http://www.w3.org/2001/XMLSchema#string